NURS 6630 Midterm Exam Psychopharmacologic Approaches to Treatment of Psychopathology Walden University — Actual Questions and Answers 100- Guarantee Pass Update Exam.pdf

NURS 6630 Midterm Exam: Psychopharmacologic Approaches to Treatment

of Psychopathology Walden University — Actual Questions and Answers

100% Guarantee Pass 2026-2027 Update Exam



Question 1

During assessment a patient states “Why are you asking me about my heart, I am here for

my head”, the PMHNP’s best response is:

Correct answer D. “Anxiety can cause cortisol levels to increase and when this

happens frequently it puts you at risk for comorbidities such as type 2 diabetes.”

Question 2

During gene expression, what must occur prior to a gene being expressed?

Correct answer A. Transcription factor must bind to the regulatory region within the

cell’s nucleus.

Question 3

The PMNHP is assessing a 29-year-old client who takes antipsychotics that block D2

receptors. This client has begun to develop a common side effect of this medication. What is

this side effect?

Correct answer D. Tardive dyskinesia

Question 4

After ordering flumazenil (Rumazicon) the PMHNP cautions the staff to monitor for which

possible effect?

,Correct answer D. All of the above

Question 5

A patient is prescribed 50 mg of desvenlafaxine to take every other day for major

depressive disorder. What does the PMHNP understand about this patient?

Correct answer C. The patient has severe renal impairment.

Question 6

A patient is prescribed sertraline to treat panic disorder. Knowing that sertraline can

initially cause anxiety or insomnia, what should the PMHNP do?

Correct answer B. Prescribe short-acting benzodiazepine for 2 weeks, then

discontinue.

Question 7

Though medications have the ability to target neurotransmitter release into the synapse by

the presynaptic neuron it is not always necessary. The PMHNP understands that this is

because:

Correct answer C. Neurotransmitters can spread by diffusion.

Question 8

A patient is diagnosed with schizophrenia. What increases the patient’s potential to

mediate the cognitive symptoms of the disease?

Correct answer A. Achieving underactivity of the mesocorticol projections to the

prefrontal cortex

Question 9

The PMHNP spends a session with a client and notices behaviors correlating with a

, potential manic episode. All of the following are possible manic symptoms the PMHNP

could observe except:

Correct answer D. A low self esteem

Question 10

A patient who is prescribed MAO inhibitors asks about whether he can continue taking

pseudoephedrine to relieve his congestion. Which response by the PMHNP indicates proper

understanding of drug-drug interactions?

Correct answer D. “Decongestants should be avoided due to risk of hypertensive

crisis.”

Question 11

Fluoxetine (Prozac) has been prescribed for a client with depression. Which of the

following statements is true regarding the action of this medication?

Correct answer B. Fluoxetine inhibits the serotonin transporter (SERT).

Question 12

A patient was diagnosed with GAD 4 weeks ago and was placed on Clonazepam (klonopin)

twice a day and citalopram (citalopram (celexa)) once daily. When he asks the PMHNP

why it is necessary to wean him off of the Clonazepam (klonopin) the best response is:

Correct answer C. Clonazepam (klonopin) was used as an aid to treat your condition

while you were adjusting to citalopram (celexa)

Question 13

Ms. Skidmore presents for a follow-up appointment after being prescribed phenelzine